Related Experiment Video
Updated: Jan 14, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
The Obesity Paradox in Chronic Total Occlusion Percutaneous Coronary Intervention: Contemporary Outcomes Across Body
Gal Sella1, Chloe Kharsa1, Yasser M Sammour1
1Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas.
Abstract:
This study examined the impact of body mass index (BMI) on procedural and long-term outcomes following percutaneous coronary intervention (PCI) for chronic total occlusion (CTO). While obesity is an established cardiovascular risk factor, an "obesity paradox" has been observed in various cardiac interventions, but contemporary data in CTO PCI are limited. We analyzed 503 consecutive CTO PCI procedures in 453 patients at our institution between January 2018 and December 2023, stratified by BMI into obese (≥30 kg/m², n = 213, 42.4%), overweight (25-29.9 kg/m², n = 194, 38.6%), and healthy weight (18.5-24.9 kg/m², n = 96, 19.1%). The primary endpoint was a composite of in-stent restenosis requiring revascularization, heart failure hospitalization, myocardial infarction, and stroke at a median follow-up of 704 days. Obese patients were younger (median 64.0 vs 67.0 vs 68.5 years, p < 0.001) and less frequently current smokers (8.5% vs 10.3% vs 19.8%, p = 0.012). Technical and procedural success were lower in obese patients (79.8% vs 75.8% vs 92.7% and 79.3% vs 75.3% vs 92.7%, respectively; p = 0.002), while radiation exposure increased significantly with BMI (median air kerma: 2385 vs 1688 vs 1126 mGy, p < 0.001). At follow-up, the composite endpoint occurred in 16.5% vs 12.3% vs 16.3% (p = 0.492), with similar all-cause mortality (3.9% vs 6.4% vs 7.0%, p = 0.425). On multivariable analysis, male sex was associated with lower risk of adverse outcomes (HR 0.53, 95% CI 0.30 to 0.95), while baseline heart failure was associated with higher risk (HR 1.83, 95% CI 1.04 to 3.25). In conclusion, despite significantly lower technical and procedural success rates and higher radiation exposure, obese patients undergoing CTO PCI had comparable long-term outcomes to healthy weight patients, supporting the obesity paradox. These findings suggest that BMI alone should not preclude CTO PCI but mandate enhanced radiation safety protocols and careful patient counseling regarding procedural success expectations.
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations

